top of page

Helius Therapeutics Partners with Novachem to Expand High-Quality NZ-Made GMP Medicinal Cannabis Products into Australia

  • Oct 7, 2024
  • 1 min read

Helius Therapeutics, New Zealand's largest and most advanced medicinal cannabis company, is thrilled to announce a strategic partnership with Novachem, a leading Australian distributor of medicinal cannabis products. This collaboration will see Novachem serve as the sponsor and primary distributor for a range of Helius Therapeutics’ New Zealand-grown, New Zealand-made, GMP-certified medicinal cannabis products in Australia, offering a wider range of product options for Australian patients.





Since 2021, Helius Therapeutics has been dedicated to providing high-quality medicinal cannabis products to Kiwi patients. The recent changes in New Zealand’s export regulations have created an exciting opportunity for the company to extend its reach beyond New Zealand’s borders. Our state-of-the-art production facilities and unwavering commitment to research, development, and GMP standards ensure that our products are crafted with the highest levels of safety and quality.


Carmen Doran, CEO of Helius Therapeutics, shared her enthusiasm for the partnership, stating, “Our expansion into Australia represents an important milestone for Helius Therapeutics. Partnering with Novachem aligns with our mission to deliver top-tier, GMP-certified products to a broader patient base. The recent regulatory changes have made this opportunity possible, and we are excited to bring our premium products to a new market. This collaboration will enable us to extend our reach and improve the lives of more patients in need of advanced medicinal cannabis treatments.”


This partnership marks a significant step forward for both Helius Therapeutics and Novachem. By combining our strengths, we are set to enhance the availability of premium medicinal cannabis products and advance the standards of care for Australian patients.

55 Comments


daniel.reedk
2 days ago

Expanding NZ made GMP medicinal cannabis through a Novachem partnership sounds like a careful step for patient access. I'd create and save the announcement details in Pixlio for reference later.

Like

Ansar Javeed
Ansar Javeed
Jun 01

يساعد فضاء الاولياء على تنظيم عملية متابعة الدراسة من خلال أدوات إلكترونية حديثة. يمكن للأولياء الاطلاع على البيانات التعليمية المختلفة ومراقبة تطور المستوى الدراسي للأبناء.

Like

Eric
Eric
May 23

This is fantastic news for medicinal cannabis patients in Australia! Helius Therapeutics' commitment to GMP-certified, NZ-made products, now distributed by Novachem, will undoubtedly enhance accessibility and quality. It's great to see such positive developments in the industry. For anyone looking for high-quality tools, check out Image to SVG.

Like

Adam Smith
Adam Smith
May 12

Usually account login pages on gaming platforms become irritating because they either take forever to respond or repeatedly ask users to verify information during sign-in sessions from mobile devices. Yesterday night I tried accessing my account again after a long time while relaxing at home, expecting at least a few interruptions during the process online. Surprisingly, BDG Win login stayed smooth throughout browsing sessions, and even moving between different sections felt much more comfortable compared to several similar platforms I have used recently online.

Like

Steve Vermillion
Steve Vermillion
May 01

The partnership shows how growth comes from working together. I remember researching instant car insurance quote from Alpa Insurance during exams, trying to save time while staying focused on my goals.

Like

Join our community

© Helius Therapeutics 2021

bottom of page